Posted Oct. 16, 2013 at 9:33 a.m.

Premium Lock G1 Therapeutics lands $12.5M in venture capital

Published: 2013-10-16 09:33:02
Updated: 2013-10-16 09:33:02

G1 Therapeutics G1 Therapeutics

The Chapel Hill-based drug startup lands MedImmune, Hatteras Venture Partners and Mountain Group Capital as investors in the Series A round. G1, once known as G-Zero Therapeutics, is developing a treatment to prevent damage to bone marrow from radiation or chemotherapy. The technology is also being studied as a way to protect the kidney....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders